USNZ Xtrackers Net Zero Pathway Paris Aligned US Equity ETF

Expense Ratio
0.1%
Dividend
0.95%
Previous close
$47.12
Est. 12 months change
+15.70%
Projected Price
$54.52

Profitability Metrics

Return on Equity (ROE)
51.57%
Return on Assets (ROA)
16.01%
Return on Invested Capital (ROIC)
38.88%
Weighted Average Cost of Capital (WACC)
10.32%
ROIC - WACC
28.56%
Updated : 2026-05-25 19:07 ET

Valuation Metrics

P/E Ratio
27.08
Forward P/E
21.92
PEG Ratio
2.03
Debt Current Ratio
1.83

Growth & Cash Flow

Gross Margin
58.84%
Operating Margin
31.71%
FCF Margin
25.59%
TTM Revenue Growth
26.93%
Projected 12M EPS Growth
23.54%

Price Change

Price % from 50 SMA
8.15%
Price % from 200 SMA
10.07%
6 Months
12.64%
1 Year
28.24%
2 Years
37.53%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
NVDA10.25%
AAPL8.70%
MSFT6.08%
AMZN4.20%
GOOGL4.18%
GOOG3.51%
AVGO3.18%
META2.34%
TSLA2.01%
MU1.53%

ETF Analysis

Fund Overview

Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USNZ) currently reports 303 stock positions (subject to change), placing it in the broadly diversified range by holdings breadth. The top line-up is NVDA (10.25%), AAPL (8.70%), MSFT (6.08%), with NVDA as the largest single weight at 10.25%. Together, the top three holdings account for 25.03%, which indicates that performance drivers are distributed more evenly across the broader basket. This architecture allows the fund to express a clear investment thesis at the top while relying on the broader basket to manage idiosyncratic volatility.

Profitability & Capital Efficiency

From a capital efficiency perspective, ROIC is 38.88%, WACC is 10.32%, and the economic spread is 28.56%. On balance, the portfolio's holdings exhibit an exceptional economic spread, compounding intrinsic value at a rate few funds can match. Supporting metrics show ROE at 51.57% and ROA at 16.01%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

Valuation currently screens at trailing P/E of 27.08, forward P/E of 21.92, PEG of 2.03. Trailing and forward multiples are somewhat apart, indicating the market is pricing measured earnings growth without aggressive expansion assumptions. Growth-adjusted valuation is in a reasonable range, with the multiple broadly in line with expected earnings expansion. At 1.83, the aggregate current ratio indicates adequate but not exceptional balance sheet coverage. The valuation profile here is neither obviously cheap nor dramatically expensive — a setup where the return case is built more on earnings delivery than on re-rating potential.

Margins & Cash Generation

On the margin front: gross margin sits at 58.84%, operating margin at 31.71%, and free cash flow margin at 25.59%. At this level, the portfolio reflects reasonable cost discipline and adequate pricing leverage at the production layer. The operating margin here is a standout — reflecting businesses that convert a large share of gross profit into operating earnings. At this FCF margin level, the underlying holdings have considerable financial flexibility without reliance on external financing. The margin trifecta here — strong at gross, operating, and free cash flow levels — is a hallmark of competitively advantaged businesses.

Growth & Forward Outlook

On the forward picture: TTM revenue growth of 26.93% reflecting robust top-line expansion across the underlying holdings. Consensus EPS estimates point to 23.5% earnings growth over the next 12 months — a compelling near-term earnings catalyst that, if delivered, changes the valuation conversation materially. Analyst price targets suggest street expectations imply a constructive but measured return profile on a 12-month view. Revenue growth is grounded in reported results; price targets are forward projections that embed assumptions about multiple expansion, earnings delivery, and macro conditions. The key risk in both directions is whether the underlying businesses can maintain their operating trajectory as macro and sector conditions evolve. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

Across the metrics reviewed, the evidence is consistently constructive — quality, growth, and valuation are pulling in the same direction.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.